Parametrica Management Ltd
Long book
$88.0M
Q1 2026
Positions
20
Top-10 weight
85%
concentration
Last quarter
+15.4%
SPY +14.8%
Turnover
32%
of book per quarter
Strategy in plain words
auto-generated from filingsParametrica Management Ltd is an institutional manager, running a $88.0M US long book across 20 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: SPDR GOLD SHARES, FIRST SOLAR INC, ALPHABET INC-CL A, MICRON TECHNOLOGY INC, NVIDIA CORP.
Over the last 9 quarters its long book ran on average 0.5pp per quarter behind the S&P 500, beating the index in 4 of 9 quarters. Signal value of individual moves is limited — treat changes as weak evidence.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+7.6%
Q2 2024
+5.8%
Q3 2024
-1.7%
Q4 2024
-8.3%
Q1 2025
+9.0%
Q2 2025
+21.3%
Q3 2025
-0.3%
Q4 2025
-12.7%
Q1 2026
+15.4%
Sector allocation
Technology 71%
Financials 12%
Industrials 11%
Services media 4%
Healthcare 2%
Long book by quarter
What does Parametrica Management own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| FSLR FIRST SOLAR INC | Technology | 35.0K | $6.9M | 7.9% | +27.1% |
| GOOGL ALPHABET INC-CL A | Technology | 23.4K | $6.7M | 7.6% | -12.0% |
| MU MICRON TECHNOLOGY INC | Technology | 19.8K | $6.7M | 7.6% | New |
| NVDA NVIDIA CORP | Technology | 38.2K | $6.7M | 7.6% | +28.7% |
| NU NU HOLDINGS LTD/CAYMAN ISL-A | Financials | 378.3K | $5.4M | 6.2% | +145.1% |
| CAT CATERPILLAR INC | Industrials | 7.0K | $5.0M | 5.6% | New |
| META META PLATFORMS INC-CLASS A | Technology | 8.2K | $4.7M | 5.3% | -19.7% |
| MELI MERCADOLIBRE INC | Services media | 701 | $1.2M | 1.4% | Held |
| IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 195.9K | $688K | 0.8% | Held |
| GRAB GRAB HOLDINGS LTD - CL A | Services media | 150.0K | $549K | 0.6% | -68.8% |
| IPSC CENTURY THERAPEUTICS INC | Healthcare | 27.8K | $63K | 0.1% | Held |
| FATE FATE THERAPEUTICS INC | Healthcare | 18.5K | $22K | 0.0% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 11, 2026 | 20 | $88.0M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 10, 2026 | 22 | $64.9M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 12, 2025 | 23 | $64.6M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 11, 2025 | 27 | $53.8M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 8, 2025 | 23 | $59.4M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 12, 2025 | 65 | $75.7M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 5, 2024 | 62 | $84.0M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 8, 2024 | 21 | $75.6M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 10, 2024 | 24 | $69.3M | canonical | SEC ↗ |
Similar funds
MASSACHUSETTS FINANCIAL SERVICES CO /MA/JENNISON ASSOCIATES LLCNational Pension ServiceFIL LtdClearbridge Investments, LLCDZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am MainNORDEA INVESTMENT MANAGEMENT ABBoston PartnersSwedbank AB1832 Asset Management L.P. HARRIS ASSOCIATES L PLOOMIS SAYLES & CO L P